Molecular Characterization and Therapeutic Potential of a Marine Bacterium Pseudoalteromonas sp. KMM 701 α-Galactosidase

An α-galactosidase capable of converting B red blood cells into the universal blood type cells at the neutral pH was produced by a novel obligate marine bacterium strain KMM 701 (VKM B-2135 D). The organism is heterotrophic, aerobic, and halophilic and requires Na⁺ ions and temperature up to 34°C for its growth. The strain has a unique combination of polysaccharide-degrading enzymes. Its single intracellular α-galactosidase exceeded other glycoside hydrolases in the level of expression up to 20-fold. The α-galactosidase was purified to determine the N-terminal amino acid sequences and new activities. It was found to inhibit Corynebacterium diphtheria adhesion to host buccal epithelium cell surfaces with high effectiveness. The nucleotide sequence of the homodimeric α-galactosidase indicates that its subunit is composed of 710 amino acid residues with a calculated Mr of 80,055. This α-galactosidase shares structural property with 36 family glycoside hydrolases. The properties of the enzyme are likely to be highly beneficial for medicinal purposes.